Investing Ideas
/
Global High Growth Potential Companies

Global High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

8526

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

8,526 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield	Industry
MX1 Micro-X	AU$0.078	-12.4%	-38.8%	AU$45.4m	AU$0.19	PS3x	E68.7%	n/a	Healthcare
ICOP I.CO.P.. Società Benefit	€7.90	1.3%	n/a	€218.3m	€9.80	PE43.2x	E49.2%	n/a	Capital Goods
AGP Altea Green Power	€5.60	1.1%	-22.7%	€97.0m	€12.85	PE14.3x	E22.1%	n/a	Capital Goods
PHM Pharma Mar	€92.65	11.6%	152.0%	€1.6b	€86.40	PE2592.7x	E44.1%	0.7%	Pharmaceuticals & Biotech
MBTN Meyer Burger Technology	CHF 1.80	-8.1%	-98.1%	CHF 55.6m	CHF 6.03	PS0.6x	E109.3%	n/a	Semiconductors
RHM Rheinmetall	€755.40	3.3%	130.2%	€32.8b	€769.79	PE47.9x	E29.9%	0.8%	Capital Goods
GUINNESS Guinness Nigeria	₦77.00	0%	20.9%	₦168.7b	₦74.24	PS0.4x	E119.5%	0%	Food, Beverage & Tobacco
INIT Initiator Pharma	SEK 7.30	-1.4%	-14.1%	SEK 409.8m	SEK 22.50	PB16.9x	E31.7%	n/a	Pharmaceuticals & Biotech
AFISH Arctic Fish Holding	NOK 67.50	-1.5%	12.5%	NOK 2.2b	NOK 81.00	PE65.7x	E65.5%	n/a	Food, Beverage & Tobacco
MVW M Vest Water	NOK 9.90	4.2%	14.8%	NOK 323.9m	NOK 11.70	PS16.9x	E71.7%	n/a	Materials
ACE Ascelia Pharma	SEK 2.92	-4.6%	-66.2%	SEK 280.1m	SEK 8.25	PB2.6x	E47.2%	n/a	Pharmaceuticals & Biotech
FND Findi	AU$4.33	-2.0%	175.8%	AU$212.6m	AU$9.00	PS3.2x	E110.7%	n/a	Diversified Financials
ELABS Elliptic Laboratories	NOK 11.36	1.8%	-30.6%	NOK 1.2b	NOK 19.00	PS12.8x	E121.1%	n/a	Software
AXSM Axsome Therapeutics	US$106.46	3.2%	14.7%	US$5.3b	US$135.13	PS15.2x	E58.0%	n/a	Pharmaceuticals & Biotech
ALNY Alnylam Pharmaceuticals	US$271.31	-2.7%	56.8%	US$35.7b	US$299.74	PS16.7x	E56.7%	n/a	Pharmaceuticals & Biotech
GAU Galiano Gold	CA$1.60	-4.2%	30.1%	CA$424.2m	CA$3.12	PS1.7x	E65.4%	n/a	Materials
KINS Kingstone Companies	US$16.99	11.6%	434.3%	US$205.0m	US$18.00	PE13.2x	E24.9%	0%	Insurance
LAVV3 Lavvi Empreendimentos Imobiliários	R$8.68	10.3%	13.2%	R$1.7b	R$12.65	PE5.5x	E20.5%	3.3%	Real Estate Management and Development
ALKT Alkami Technology	US$34.79	-1.1%	41.5%	US$3.6b	US$45.10	PS11.1x	E102.7%	n/a	Software
ZVRA Zevra Therapeutics	US$7.84	-2.5%	35.6%	US$428.1m	US$20.63	PS17.1x	E57.8%	n/a	Pharmaceuticals & Biotech
ONON On Holding	US$59.88	-0.4%	116.2%	US$20.4b	US$62.47	PE138.6x	E29.7%	n/a	Consumer Durables
TVTX Travere Therapeutics	US$20.46	0.7%	141.0%	US$1.8b	US$28.47	PS8.8x	E62.1%	n/a	Pharmaceuticals & Biotech
RCEL AVITA Medical	US$9.10	-2.4%	-46.2%	US$250.3m	US$17.08	PS4x	E51.9%	n/a	Pharmaceuticals & Biotech
PRL Propel Holdings	CA$38.54	-8.7%	144.7%	CA$1.6b	CA$45.92	PE23.8x	E38.9%	1.6%	Diversified Financials

Page 1 of 356